RB
Roy D. Baynes

Roy D. Baynes insider trades: Travere Therapeutics (TVTX) stock sales

Travere Therapeutics Last trade Jun 12, 2026 58 Form 4 filings
$4.9M
Sold, last 12 months
5 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2020
7
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Roy reports to the SEC

and 1 more company

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 12, 2026TVTX↓ Sell$225K
May 5, 2026TVTX↓ Sell$210K
Apr 14, 2026TVTX↓ Sell$1.4M
Apr 6, 2026TVTX↓ Sell$330K
Nov 20, 2025NTRA↓ Sell10b5-1$2.8M
Feb 6, 2025TVTX↓ Sell$220K
Jan 23, 2025TVTX↓ Sell$320K
Nov 15, 2024NTRA↓ Sell10b5-1$5.4M
Aug 7, 2020NTRA↓ Sell$70K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other TVTX insiders

Open-market trades in the last 12 months

About Roy D. Baynes's insider trades

Roy D. Baynes is an insider at Travere Therapeutics (TVTX). Since Aug 7, 2020, Roy has reported no open-market purchases and 9 sales worth $11.0M on SEC Form 4. In the last 12 months: 5 sales ($4.9M).

2 sales (75% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include grants and awards (47 filings), option exercises (12 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TVTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.